337 related articles for article (PubMed ID: 25518744)
1. Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
Ooms G; Forman L; Williams OD; Hill PS
BMC Int Health Hum Rights; 2014 Dec; 14():37. PubMed ID: 25518744
[TBL] [Abstract][Full Text] [Related]
2. Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?
Assefa Y; Hill PS; Ulikpan A; Williams OD
Global Health; 2017 Sep; 13(1):73. PubMed ID: 28903757
[TBL] [Abstract][Full Text] [Related]
3. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
McGIVERN L
Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
[TBL] [Abstract][Full Text] [Related]
4. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
Allard Soto R
Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
[TBL] [Abstract][Full Text] [Related]
5. Compulsory licensing often did not produce lower prices for antiretrovirals compared to international procurement.
Beall RF; Kuhn R; Attaran A
Health Aff (Millwood); 2015 Mar; 34(3):493-501. PubMed ID: 25732501
[TBL] [Abstract][Full Text] [Related]
6. Differential pricing for pharmaceuticals: reconciling access, R&D and patents.
Danzon PM; Towse A
Int J Health Care Finance Econ; 2003 Sep; 3(3):183-205. PubMed ID: 14625999
[TBL] [Abstract][Full Text] [Related]
7. Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016.
't Hoen EF; Veraldi J; Toebes B; Hogerzeil HV
Bull World Health Organ; 2018 Mar; 96(3):185-193. PubMed ID: 29531417
[TBL] [Abstract][Full Text] [Related]
8. Legal and policy foundations for global generic competition: Promoting affordable drug pricing in developing societies.
Zapatero Miguel P
Glob Public Health; 2015; 10(8):901-16. PubMed ID: 25737069
[TBL] [Abstract][Full Text] [Related]
9. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
10. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil.
Rosenberg ST
Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542
[TBL] [Abstract][Full Text] [Related]
11. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Adekola TA
Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
[TBL] [Abstract][Full Text] [Related]
12. Compulsory Licensing of Pharmaceuticals in High-Income Countries: A Comparative Analysis.
Qunaj L; Kaltenboeck A; Bach PB
Milbank Q; 2022 Mar; 100(1):284-313. PubMed ID: 35257415
[TBL] [Abstract][Full Text] [Related]
13. Compulsory licensing of pharmaceuticals reconsidered: Current situation and implications for access to medicines.
Son KB; Lee TJ
Glob Public Health; 2018 Oct; 13(10):1430-1440. PubMed ID: 29183271
[TBL] [Abstract][Full Text] [Related]
14. Cautionary Notes on a Global Tiered Pricing Framework for Medicines.
Williams OD; Ooms G; Hill PS
Am J Public Health; 2015 Jul; 105(7):1290-3. PubMed ID: 25973806
[TBL] [Abstract][Full Text] [Related]
15. Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
Bird RC
J Law Med Ethics; 2009; 37(2):209-21. PubMed ID: 19493067
[TBL] [Abstract][Full Text] [Related]
16. The right to health and medicines: the case of recent multilateral negotiations on public health, innovation and intellectual property.
Velasquez G
Dev World Bioeth; 2014 Aug; 14(2):67-74. PubMed ID: 24813066
[TBL] [Abstract][Full Text] [Related]
17. WTO approves TRIPS amendment on importing under compulsory licensing.
Herget G
HIV AIDS Policy Law Rev; 2006 Apr; 11(1):23-4. PubMed ID: 16805011
[TBL] [Abstract][Full Text] [Related]
18. An economic justification for open access to essential medicine patents in developing countries.
Flynn S; Hollis A; Palmedo M
J Law Med Ethics; 2009; 37(2):184-208. PubMed ID: 19493066
[TBL] [Abstract][Full Text] [Related]
19. Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals.
Babovic S; Wasan KM
J Pharm Sci; 2011 Mar; 100(3):816-21. PubMed ID: 20740678
[TBL] [Abstract][Full Text] [Related]
20. Access to critical medicines: When are compulsory licenses effective in price negotiations?
Ramani SV; Urias E
Soc Sci Med; 2015 Jun; 135():75-83. PubMed ID: 25957163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]